David MADDEN,Kathleen GABRIEL,Guido MAGNI,Richard WOODWARD
申请号：
US16256221
公开号：
US20190225696A1
申请日:
2019.01.24
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention provides a method of reducing the severity of, or treating, thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' ophthalmopathy or orbitopathy (GO), as well as antibodies, or antigen binding fragments thereof, and pharmaceutical compositions comprising them, useful in the methods.
